Daclizumab and kidney transplant rejection Patient Reports February 12, 2012
Daclizumab Side Effects Report #4549520-X
Daclizumab side effect was reported by a Physician from on May 26, 2004. Female patient, 64 years of age, weighting 134.5 lb, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: kidney transplant rejection, urinary tract infection
, urosepsis. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, SIROLIMUS. Patient was hospitalized. Patient recovered.Daclizumab Side Effects Report #4698307-6
Daclizumab side effect was reported by a Physician from on May 26, 2004. Female patient, 64 years of age, weighting 134.5 lb, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: blood creatinine increased, kidney transplant rejection, urinary tract infection
, urosepsis. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, SIROLIMUS. Patient was hospitalized. Patient recovered.Daclizumab Side Effects Report #4705239-3
Daclizumab side effect was reported by a Physician from GERMANY on May 26, 2004. Female patient, 64 years of age, weighting 134.5 lb, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: kidney transplant rejection, urinary tract infection
, urosepsis. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, SIROLIMUS. Patient was hospitalized. Patient recovered.Daclizumab Side Effects Report #4879135-5
Daclizumab side effect was reported by a Physician from ISRAEL on Aug 10, 2004. Male patient, 43 years of age, weighting 218.3 lb, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: arthritis
, kidney transplant rejection, klebsiella sepsis, pneumonia
, pyrexia. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, SIROLIMUS, PREDNISONE. Patient was hospitalized. Patient recovered.Daclizumab Side Effects Report #4707119-6
Daclizumab side effect was reported by a Physician from BRAZIL on Feb 05, 2004. Male patient, 35 years of age, weighting 136.7 lb, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, gastroenteritis
, haemodialysis, hiatus hernia, kidney transplant rejection, metabolic acidosis, pneumonia
. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.Daclizumab Side Effects Report #4570323-4
Daclizumab side effect was reported by a Physician from on Dec 18, 2003. Male patient, 34 years of age, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: blood creatinine increased, hypertension, kidney transplant rejection, renal artery stenosis. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, CYCLOSPORINE, METHYLPREDNISOLONE, TACROLIMUS. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #4638993-X
Daclizumab side effect was reported by a Physician from on Dec 18, 2003. Male patient, 34 years of age, weighting 160.9 lb, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: blood creatinine increased, diarrhoea, hypertension, kidney transplant rejection, renal artery stenosis. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, CYCLOSPORINE. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #4617085-X
Daclizumab side effect was reported by a Physician from on Aug 02, 2004. Female patient, 31 years of age, weighting 132.5 lb, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: complications of transplanted kidney, cytomegalovirus infection
, kidney transplant rejection, polyomavirus interstitial nephritis. Daclizumab dosage: DOSE = 125 MG.. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, ENCORTON, COTRIMOXAZOL. Patient was hospitalized. Patient recovered.Daclizumab Side Effects Report #4630701-1
Daclizumab side effect was reported by a Physician from on Jan 18, 2005. Female patient, child 3 years of age, weighting 45.19 lb, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: atherosclerosis, blood creatinine increased, fluid overload, graft complication, kidney transplant rejection, oliguria, renal cyst, upper respiratory tract infection. Daclizumab dosage: 40 MG GIVEN ON 06 JANUARY 2005.. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, PROGRAF, MANNITOL, DOPAMINE. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5126854-1
Daclizumab side effect was reported by a Physician from FRANCE on Oct 03, 2006. Male patient, 22 years of age, weighting 114.0 lb, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: kidney transplant rejection, urine analysis abnormal, viral infection
. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, SIROLIMUS, CYCLOSPORINE, CORTICOSTEROID NOS. Patient was hospitalized. Patient recovered.Daclizumab Side Effects Report #5133677-6
Daclizumab side effect was reported by a Physician from FRANCE on Oct 03, 2006. Male patient, 22 years of age, weighting 114.0 lb, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: blood creatine increased, kidney transplant rejection, myalgia, pyrexia, thrombocytopenia, viral infection
. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, SIROLIMUS, CYCLOSPORINE, CORTICOSTEROID NOS, TENORMIN. Patient was hospitalized. Patient recovered.
Daclizumab and kidney transplant rejection 